EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

The Prognostic Significance of NEDD9 Expression in Human Cancers: A Systematic Review, Meta-Analysis, and Omics Exploration

Jehad A Yasin iD, Ramez M Odat, Fares A Qtaishat, Mohammad-Amer A Tamimi iD, Muaath I Alsufi, Osama M Younis, Leen A Alkuttob, Anwaar Saeed

Technology in Cancer Research & Treatment · 2024-01 · 23

DOI: 10.1177/15330338241297597 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 14.11.2024. Verfasst von Jehad A Yasin und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, The University of Jordan, Amman, Jordan. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Biomarkers, Tumor, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neural precursor cell expressed developmentally downregulated 9 (NEDD9) is considered an important factor in the progression of cancer, acting as a modulator of cellular migration, adhesion, and metastatic potential. Its significance as a prognostic factor, however, remains unclear, which necessitated a comprehensive review and meta-analysis.

Methods

Our study followed the PRISMA guidelines, analyzing studies from major databases including PubMed, Embase, and Cochrane. Our eligibility criteria included studies evaluating NEDD9 expression in relation to cancer prognosis and outcomes such as overall survival (OS), progression-free survival (PFS), disease-free Survival (DFS), recurrence-free survival (RFS), and cancer-specific survival (CSS). We used random-effects and fixed-effect models for meta-analysis, and we validated our findings by comparative analysis using data from external cohorts like The Cancer Genome Atlas (TCGA).

Results

The analysis of 27 studies with 3915 patients demonstrated a significant relationship between NEDD9 expression and poor OS as indicated by the pooled meta-analysis outcome across all included cancers (HR: 1.81, 95% CI: 1.38-2.37). A significant effect on PFS/DFS/RFS/CSS was also found (HR: 2.14, 95% CI: 1.42-3.23). Variations in survival across different types of cancer were indicated by subgroup analysis. NEDD9 expression was correlated with various immune cells across cancer types according to immune infiltration analysis. Protein-protein interaction (PPI) analysis indicated significant interactions involving NEDD9, suggesting mechanisms which influence tumor behavior and response to treatment.

Conclusion

Our results suggest that NEDD9 is a significant prognostic marker in several human cancers. As a result of its central role in cancer progression and prognosis, it presents a promising target for therapeutic interventions. Our study highlights the importance of further research into the biology of NEDD9 and its therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adaptor Proteins, Signal TransducingBiomarkers, TumorNeoplasmsHumansComputational BiologyGene Expression Regulation, NeoplasticPrognosisProtein Interaction Maps

Stichwörter der Autor:innen

NEDD9 proteincancer metastasisgene expression profilinghumanmeta-Analysisoncologyprognostic biomarkerssignal transductionsurvival analysissystematic reviewthe cancer genome atlas

Substanzen

Adaptor Proteins, Signal TransducingBiomarkers, TumorNEDD9 protein, human

Autor:innen und Institutionen

  • School of Medicine, The University of Jordan, Amman, Jordan.
  • Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
  • Division of Hematology & Oncology, Department of Medicine, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA 15232, USA.

ORCID-Profile: Jehad A Yasin, Mohammad-Amer A Tamimi

Zitieren

APA

Yasin, J. A., Odat, R. M., Qtaishat, F. A., Tamimi, M. A., Alsufi, M. I., Younis, O. M., Alkuttob, L. A., & Saeed, A. (2024). The Prognostic Significance of NEDD9 Expression in Human Cancers: A Systematic Review, Meta-Analysis, and Omics Exploration. Technology in Cancer Research & Treatment, 23. https://doi.org/10.1177/15330338241297597

Vancouver

Yasin JA, Odat RM, Qtaishat FA, Tamimi MA, Alsufi MI, Younis OM, et al. The Prognostic Significance of NEDD9 Expression in Human Cancers: A Systematic Review, Meta-Analysis, and Omics Exploration. Technology in Cancer Research & Treatment. 2024;23. doi:10.1177/15330338241297597

BibTeX
@article{Yasin2024,
  author = {Yasin, Jehad A and Odat, Ramez M and Qtaishat, Fares A and Tamimi, Mohammad-Amer A and Alsufi, Muaath I and Younis, Osama M and Alkuttob, Leen A and Saeed, Anwaar},
  title = {The Prognostic Significance of NEDD9 Expression in Human Cancers: A Systematic Review, Meta-Analysis, and Omics Exploration},
  journal = {Technology in Cancer Research & Treatment},
  year = {2024},
  volume = {23},
  doi = {10.1177/15330338241297597}
}
Kostenlos starten →